The cumulative use of strong anticholinergics is associated with an increased risk for dementia in a dose-response pattern; ...
As cities around the world grapple with escalating mental health challenges, researchers from The University of Hong Kong ...
Wellbeing Whisper on MSN
Walking 3,000–7,500 Steps Daily May Delay Alzheimer’s by Years
Every step counts and even small increases in daily activities can build over time to create sustained changes in habit and ...
Risankizumab (Skyrizi), a selective anti-interleukin-23 (IL-23) biologic agent, is increasingly used in the treatment of Crohn's disease (CD). A previous head-to-head study has demonstrated its ...
The substantial use of Benzene in the creation of different polymers, resins, and man-made fibers makes the chemical an unavoidable material across different industries. Being able to identify the ...
INCHEON, South Korea--(BUSINESS WIRE)--Celltrion today announced two-year results of subcutaneous infliximab (CT-P13 SC) dose escalation therapy at United European Gastroenterology (UEG) Week 2024 in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback